- Fiocchi C. Inflammatory bowel disease: etiology and pathogen esis. Gastroenterology 1998;115:182-205.
- Blumberg RS. Role of epithelial cell in IBD. In: Emmrich J, Liebe S, Stange EF, editors. Innovative concepts in inflammatory bowel disease. Dordrecht: Kluwer Academic Publishers; 1999. p. 155-72.
- Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 1998;43:735-6.
- Kosiewicz MM, Nast CC, Krishnan A, Rivera-Nieves J, Moskaluk CA, Matsumoto S, et al. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 2001;107:667-70.
- El-Zaatari FA, Osato MS, Graham DY. Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends MoI Med 2001 ;7:247-52.
- Harris JE, Lammerding AM. Crohn's disease and Mycobacterium avium subsp. paratuberculosis : current issues. J Food Prot 2001:64:2103-10.
- Thorel MF. Relationship between Mycobacterium avium, M. paratuberculosis and mycobacteria associated with Crohn's disease. Ann Rech Vet 1989;20:417-29.
- Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, et al. Review article: Mycobacterium avium subsp. paratuberculosi s as one cause of Crohn's disease. Aliment Pharmacol Ther 2001; 15:337-46.
- Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-61.
- Senger DR, Asch BB, Smith BD, Pertuzzi CA, Dvorak HF. A secreted phosphoprotei n marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 1993:302:714-15.
- Patarca R, Freeman GJ, Singh RP, Wie FY, Durfee T, Blattner F, et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T-cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 1989:170:145-61.
- Cantor H. The role of Eta-1/osteopontin in the pathogenesis of immunological disorders. Ann NY Acad Sci 1995:760:143-50.
- Denhardt DT, Giachelli CM, Kittling SR. Role of osteopontin in cellular signaling and toxicant injury. Ann Rev Pharmacol Toxicol 2001:41:723-49.
- O'Regan A, Berman JS. Osteopontin: a key cytokine in cellmediated and granulomatous inflammation. Int J Exp Path 2000:81:373-90.
- Brown LF, Berse B, van de Water L, Papadopoulos-Sergiou A, Penuzzi CA, Manseau EJ, et al. Expression and distribution of osteopontin in human tissues. Widespread association with luminal epithelial surfaces. MoI Biol Cell 1992:3:1169-80.
- Qu-Hong, Dvorak AM. Ultrastructural localization of osteopontin immunoieactivity in phagolysosomes and secretory granules of cells in human intestine. Histochem J 1997;29:801 -12.
- Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287:860-4.
- Atkins KB, Berry JE, Zhang WZ Harris JF, Chambers AF, Simpson RU, et al. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells. J Cell Physiol 1998:175:229-37.
- Rollo EE, Laskin DL, Denhardt DT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. J Leukocyte Biol 1996:60:397-404.
- Obermüller N, Gretz N, Kriz W, Reilly RF, Witzgall R. The swelling-activated channel C1C-2, the channel C1C-3, and C1C-5, a channel mutated in kidney stone disease, are expressed in distinct renal epithelial cells. J Clin Invest 1998:101:635-42.
- Nau GJ, Guilfoile P, Chupp GL, Hermann JS, Kim SJ, Kornfeld H, et al. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci USA 1997; 94:6414-9.
- Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, et al. Cellular proliferation and macrophage influx precede interstitial flbrosis in cylosporine nephrotoxicity. Kidney Int 1995:48:439-48.
- Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermüller N, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001;281:G216-28.
- Autschbach F, Palou E, Mechtersheimer G, Rohr C, Pirotto F, Gassler N, et al. Expression of the membrane protein tyrosine phosphatese CD 148 in human tissues. Tissue Antigens 1999;54: 485-98.
- Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, Alpers CE. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 1999;10:444-57.
- Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, et al. Coupling of osteopontin and its cell surrace receptor CD44 to the cell survival response elicited by interleuktn-3 or granulocytemacrophage colony-stimulating factor. MoI Cell Biol 2000;20: 2734-42.
- Itoh J, de la Motte C, Strong SA, Levine AD, Fiocchi C. Decrease Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001:49:35-41.
- Di Sabatino A, Corazza GR. Surviving too long in Crohn's disease. Gut 2001;49:6-8.
- Autschbach F, Giese T, Gassier N, Sido B, Keuschen G, Keuschen U, et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 2002. In press.
- Kittling SR, Denhardt DT. Osteopontin function in pathology: lessons from osteopontin-deflcient mice. Exp Nephrol 1999;7: 103-13.
- Otto HF, Remmele W. Kolon und Rektum. In: Remmele W, editor. Pathologie. 2nd edn. Berlin: Springer; 1996. p. 591-616.
Scandinavian Journal of Gastroenterology
Volume 37, 2002 - Issue 11